Presentations

Interim Report Q3 2023/2024 (in Swedish)

Interim Report Q2 2023/2024 (in Swedish)

Interim Report Q1 2023/2024 (in Swedish)

Year-end report 2022/2023 (in Swedish)

Interim Report Q3 2022/2023 (in Swedish)

We are EQL Pharma 2023-02-14 (in Swedish)

Capital Markets Day 2022-11-24 (in Swedish)

Interview with our CEO Axel Schörling (in Swedish)